|
Sanmartin Fernandez M, Anguita Sanchez M, Arribas F, Baron-Esquivias G, Barrios V, Cosin-Sales J, Esteve-Pastor MA, Freixa-Pamias R, Lekuona I, Perez-Cabeza AI, Urena I, Vazquez Rodriguez JM, Rafols Priu C, Marin F. Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study. Cardiol J. 2022;29(4):601-609. doi: 10.5603/CJ.a2022.0044. Epub 2022 May 27. PubMed PMID: 35621092; PubMed Central PMCID: PMC9273239.
AÑO: 2022; IF: 2.9
|
35621092
|
Rivera-Caravaca JM, Badimon L, Ferreira-Gonzalez I, Gomez-Doblas JJ, Roca-Luque I, Lekuona I, Jimenez-Candil J, Rodriguez-Padial L, Gonzalez-Juanatey C, Calvo-Jambrina R, Facila L, Ruiz-Ortiz M, Anguita M, Marin F. Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: insights from the national and multicentre SULTAN registry. Europace. 2022 Jan 4;24(1):4-11. doi: 10.1093/europace/euab131. PubMed PMID: 34115857.
AÑO: 2022; IF: 6.1
|
|
Ding WY, Rivera-Caravaca JM, Marin F, Roldan V, Lip GYH. Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial. J Thromb Thrombolysis. 2022 Jul;54(1):1-6. doi: 10.1007/s11239-022-02638-0. Epub 2022 Apr 15. PubMed PMID: 35426602; PubMed Central PMCID: PMC9259516.
AÑO: 2022; IF: 4.0
|
|
Castellano JM, Pocock SJ, Bhatt DL, Quesada AJ, Owen R, Fernandez-Ortiz A, Sanchez PL, Marin Ortuno F, Vazquez Rodriguez JM, Domingo-Fernandez A, Lozano I, Roncaglioni MC, Baviera M, Foresta A, Ojeda-Fernandez L, Colivicchi F, Di Fusco SA, Doehner W, Meyer A, Schiele F, Ecarnot F, Linhart A, Lubanda JC, Barczi G, Merkely B, Ponikowski P, Kasprzak M, Fernandez Alvira JM, Andres V, Bueno H, Collier T, Van de Werf F, Perel P, Rodriguez-Manero M, Alonso Garcia A, Proietti M, Schoos MM, Simon T, Fernandez Ferro J, Lopez N, Beghi E, Bejot Y, Vivas D, Cordero A, Ibanez B, Fuster V; SECURE Investigators. Polypill Strategy in Secondary Cardiovascular Prevention. N Engl J Med. 2022 Sep 15;387(11):967-977. doi: 10.1056/NEJMoa2208275. Epub 2022 Aug 26. PubMed PMID: 36018037.
AÑO: 2022; IF: 158.5
|
|
Boriani G, Vitolo M, Malavasi VL, Proietti M, Fantecchi E, Diemberger I, Fauchier L, Marin F, Nabauer M, Potpara TS, Dan GA, Kalarus Z, Tavazzi L, Maggioni AP, Lane DA, Lip GYH; ESC-EHRA EORP-AF Long-Term General Registry Investigators. Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry. Eur J Prev Cardiol. 2022 Nov 8;29(15):1967-1981. doi: 10.1093/eurjpc/zwac115. PubMed PMID: 35671129.
AÑO: 2022; IF: 8.3
|